High throughput screening and accelerated pharmaco-toxicological profiling of bioactives.

This should encompass:

the development of medium throughput screening to high throughput screening of bioactive molecules by the acquistion of relevent biotechnology, followed by its enhancement leading to the development of new assays.

accelereted approach to pharmaco-toxicological profiling of biomolecules towards the ultimate application of gene chip technology. Research should be focused on key pharmacological systems of interest/value to the nation, such as the cardiovascular-renal system, central nervous system and immunological system (including endocrine system).